| 000 | 01005 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515013348.0 | ||
| 264 | 0 | _c20060223 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a1359-6535 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTremblay, Cécile L | |
| 245 | 0 | 0 |
_aTAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro. _h[electronic resource] |
| 260 |
_bAntiviral therapy _c2005 |
||
| 300 |
_a967-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xpharmacology |
| 650 | 0 | 4 | _aCCR5 Receptor Antagonists |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aSulfoxides |
| 700 | 1 | _aGiguel, Françoise | |
| 700 | 1 | _aChou, Ting-Chao | |
| 700 | 1 | _aDong, Huajin | |
| 700 | 1 | _aTakashima, Katsunori | |
| 700 | 1 | _aHirsch, Martin S | |
| 773 | 0 |
_tAntiviral therapy _gvol. 10 _gno. 8 _gp. 967-8 |
|
| 999 |
_c16045534 _d16045534 |
||